Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed
CNTB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Net Income | -55.48 | -15.63 | -62.11 | -118.09 | -202.27 | Upgrade
|
| Depreciation & Amortization | 0.7 | 0.66 | 0.72 | 1.03 | 0.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.01 | 0.1 | - | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.23 | - | 4.7 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.77 | -0.12 | -1.7 | - | - | Upgrade
|
| Stock-Based Compensation | 3.73 | 6.73 | 5.4 | 6.91 | 8.99 | Upgrade
|
| Other Operating Activities | - | - | - | -2.52 | 104.7 | Upgrade
|
| Change in Accounts Receivable | 0.78 | -0.79 | - | 4.05 | -2.31 | Upgrade
|
| Change in Accounts Payable | 1.62 | -1.87 | -1.14 | -0.78 | 8.97 | Upgrade
|
| Change in Unearned Revenue | 0 | -13.16 | 13.32 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.82 | 0.32 | -2.33 | 3.19 | -3.08 | Upgrade
|
| Operating Cash Flow | -51.21 | -23.61 | -47.74 | -101.52 | -84.32 | Upgrade
|
| Capital Expenditures | -0.43 | -0.75 | -0.08 | -4.41 | -3.83 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | 0 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | 2.94 | - | -0.05 | Upgrade
|
| Investment in Securities | 10.25 | -2.7 | 72.12 | -81.84 | 2.12 | Upgrade
|
| Other Investing Activities | - | - | - | - | -3.44 | Upgrade
|
| Investing Cash Flow | 9.82 | -3.45 | 74.98 | -86.24 | -5.21 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.22 | -0.13 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.22 | -0.13 | Upgrade
|
| Issuance of Common Stock | 1.09 | 0.23 | 0.05 | 0.14 | 220.02 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.57 | Upgrade
|
| Other Financing Activities | - | - | - | - | -17.11 | Upgrade
|
| Financing Cash Flow | 1.09 | 0.23 | 0.05 | -0.09 | 202.22 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.41 | -0.6 | -0.57 | -0.86 | 0.22 | Upgrade
|
| Net Cash Flow | -39.89 | -27.43 | 26.72 | -188.71 | 112.91 | Upgrade
|
| Free Cash Flow | -51.64 | -24.36 | -47.82 | -105.93 | -88.16 | Upgrade
|
| Free Cash Flow Margin | -80687.50% | -93.58% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.93 | -0.44 | -0.87 | -1.92 | -1.69 | Upgrade
|
| Cash Income Tax Paid | 0.29 | 0.11 | 0.12 | - | - | Upgrade
|
| Levered Free Cash Flow | -30.65 | -21.1 | -25.55 | -67.55 | -46.03 | Upgrade
|
| Unlevered Free Cash Flow | -30.65 | -21.1 | -25.55 | -67.54 | -46.02 | Upgrade
|
| Change in Working Capital | 0.58 | -15.49 | 9.85 | 6.46 | 3.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.